Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

166.18
-0.0200-0.01%
Post-market: 166.190.0101+0.01%19:55 EDT
Volume:7.15M
Turnover:1.19B
Market Cap:42.64B
PE:-11.69
High:166.85
Open:166.55
Low:165.27
Close:166.20
52wk High:176.60
52wk Low:141.05
Shares:256.62M
Float Shares:256.62M
Volume Ratio:0.83
T/O Rate:2.79%
Dividend:2.45
Dividend Rate:1.47%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.24
PE(LYR):-11.69

Loading ...

Court Dismisses Molina Healthcare Securities Fraud Complaint, Allows Plaintiff to Amend

TIPRANKS
·
Sep 28

JPMorgan Adjusts Price Target on Eli Lilly to $1,500 From $1,400, Maintains Overweight Rating

MT Newswires Live
·
Sep 28

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

GlobeNewswire
·
Sep 28

Merck's Keytruda Subcutaneous Formulation Approved for Launch in China

Stock News
·
Sep 28

Ingenia Therapeutics Expects USD 5 Million MK-8748 Milestone Payment from Merck Unit Eyebiotech

Reuters
·
Sep 28

Amvis to Launch AI-Focused Subsidiary AIZIA to Boost Healthcare Productivity

TIPRANKS
·
Sep 28

Eli Lilly's Olumiant Gets FDA Approval for Severe Alopecia Areata in Adolescents

MT Newswires Live
·
Sep 28

Austco Director Increases Shareholding After Performance Rights Vesting

TIPRANKS
·
Sep 28

Healthcare & Medical Investment Corp Secures Social Loan for 800 Million Yen Refinancing

TIPRANKS
·
Sep 28

Austco Healthcare Issues 2.7 Million New Shares on Conversion of Unquoted Securities

TIPRANKS
·
Sep 28

Market Chatter: Matrix Concepts' Healthcare Unit Invests Nearly MYR11 Million to Upgrade Infrastructure

MT Newswires Live
·
Sep 28

DKSH Expands Grünenthal Pain Management Partnership Across Eight Asia-Pacific Markets

TIPRANKS
·
Sep 28

Analysts Offer Insights on Healthcare Companies: Celldex (CLDX), Nanobiotix (NBTX) and Senseonics Holdings (SENS)

TIPRANKS
·
Sep 28

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 28

Epsilon Healthcare lifts revenue and builds integrated medicinal cannabis platform

TIPRANKS
·
Sep 28

Analyst Reiterates Buy on Nektar as Legal Overhang Clears, REZPEG Outlook Strengthens and $178 Price Target Remains Unchanged

TIPRANKS
·
Sep 28

Nektar selloff on trial brings ‘strong entry point,’ says BTIG

TIPRANKS
·
Sep 28

Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE)

TIPRANKS
·
Sep 28

Supreme Court Clears Independent Forensic Audit of Fortis Healthcare

TIPRANKS
·
Sep 27

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roivant Sciences (ROIV) and Johnson & Johnson (JNJ)

TIPRANKS
·
Sep 27